Can We Discharge TAVR Patients the Same Day?

For over a decade, TAVR has been showing great benefits, but conduction abnormalities such as RBBB and prior A-V block, continue to be one of the biggest challenges, since in different series the need for definite pacemaker implantation (PPM) varies between 17 to 30% in the large, randomized studies of self-expanding valves.  

alta en el mismo día post TAVI

Even though we are well aware a higher implantation depth of the percutaneous valve (cusp overlapping) has been shown to significantly reduce the need for PPM, it has not yet been tested in large, randomized studies. 

68,482 patients receiving TAVR via femoral approach were looked at. 20,261 (29.6%) of these patients got early discharge (ED), between 0 and 1 day, and 48,221 late discharge (LD), ≥2 days.

Primary end point was rehospitalization for PPM. 

ED patients were younger (79 ± 8 years vs. 80 ± 7.6 years p < 0.01), there were more men, fewer were diabetic or presented kidney failure, COPD, peripheral vascular disease, or stroke, and had more programmed procedures. Besides, they presented fewer conduction abnormalities such as first and second-degree AV block, RBBB and fascicular blocks. 

Read also: Heparin Pretreatment in STEACS Treatment: A New Old Ally?

There were no differences in primary end point between ED and LD patients (2.0% vs. 1.8%; adjusted odds ratio: 1.15; 95% confidence interval: 0.95–1.39; p=0.15). Neither were there differences in readmissions for PPM at 30 and 60 days, or between elective and non-elective readmission. 

Mean time for readmission was 5 days, with no differences between ED and LD.

ED was associated to lower hospital expenses compared against LD.

Read also: RIPCORD 2 Study: Routine Assessment Using Pressure Wires in Acute Coronary Syndrome.

Predictors of PPM were 2-degree A-V block, fascicular blocks, RBBB and kidney failure. 

Conclusion

Early and late discharge TAVR patients who did not require permanent pacemaker implantation during hospitalization showed similar readmission rate for pacemaker implantation. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Early versus late discharge after transcatheter aortic valve replacement and readmissions for permanent pacemaker implantation. 

Reference: Ahmed M. Elzanaty, et al. Catheter Cardiovasc Interv. 2022;100:245–253.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...